 The purpose of this study is to test the safety of RAD001 everolimus tablets at different dose levels, when added to docetaxel and cisplatin. The investigators want to find out what effects, good andor bad, that everolimus has when added to docetaxel and cisplatin as treatment for head and neck cancer. 